K

Airna logo

Airna

Recent Finacing

Series B

Recent Raise

$155M


Airna is a biotech company that specializes in RNA editing therapeutics, aiming to target diseases inaccessible through other methods, with its first program focusing on treating the inherited genetic disease alpha-1 antitrypsin deficiency (AATD).

Total Funding

$185M

Headquarters

Cambridge, USA

Founded

N/A

Website

Focus Areas

Biotech
RNA Editing Therapeutics
Genetic Disease Treatment

Investors

ARCH Venture Partners logo
ND Capital logo
RTW Investments logo
Forbion Ventures logo
Nextech Invest logo
Venrock Healthcare Capital Partners logo
Novalis logo
Fast Track Initiative logo
Codon Capital logo